3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
18
Hematologic Neoplasms
10
Prostatic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Carcinoma, Non-Small-Cell Lung
7
Anatomic Stage I Breast Cancer AJCC v8
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Malignant Solid Neoplasm
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
20
pomalidomide
18
Lenalidomide
17
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Cisplatin
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Carboplatin
7
zanubrutinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Practice Guidelines as Topic
×
1 year
×
Clear all
No trials found.